The benefit of quality control charts (QCC) for routine quantitative BCR-ABL1 monitoring in chronic myeloid leukemia.

The benefit of quality control charts (QCC) for routine quantitative BCR-ABL1 monitoring in chronic myeloid leukemia.

Quantitative real-time polymerase chain reaction (qRT-PCR) is state of the art in molecular monitoring of minimal residual disease in chronic myeloid leukemia (CML). In this context, maintenance of assay fidelity and detection of technical inaccuracy are crucial. Beside multiple common negative cont...

Full description

Bibliographic Details
Main Authors:	Birgit Spiess, Nicole Naumann, Norbert Galuschek, Sébastien Rinaldetti, Ute Kossak-Roth, Irina Tarnopolscaia, Elena Felde, Alice Fabarius, Wolf-Karsten Hofmann, Susanne Saußele, Wolfgang Seifarth
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2018-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC5916859?pdf=render

Similar Items

Reverse Transcription Can Critically Impact the Diagnostic Outcome of <i>BCR::ABL1</i> Quantitative Real-Time RT-PCR
by: Birgit Spiess, et al.
Published: (2023-08-01)

A new aberrantly spliced BCR‐ABL1 transcript variant (e13a1) identified in routine monitoring using different quantitative reverse transcription polymerase chain reaction techniques in a patient with chronic myeloid leukemia
by: Nicole Naumann, et al.
Published: (2022-11-01)

Gene Expression Pattern of <em>ESPL1</em>, <em>PTTG1</em> and <em>PTTG1IP</em> Can Potentially Predict Response to TKI First-Line Treatment of Patients with Newly Diagnosed CML
by: Eva Christiani, et al.
Published: (2023-05-01)

Spektrum QCC
Published: (1986)

QCC annual
by: Perbadanan Produktiviti Negara
Published: (1992)

Clonal Evolution and Blast Crisis Correlate with Enhanced Proteolytic Activity of Separase in BCR-ABL b3a2 Fusion Type CML under Imatinib Therapy.
by: Wiltrud Haaß, et al.
Published: (2015-01-01)

QCC in public sector /
by: 459751 Jenkins, Kenneth M., et al.

Getting started in QCC
Published: (1990)

QCC circles : [proceedings] /
by: International Convention on QC Circles (1993 : Bangkok, Thailand), et al.
Published: (1993)

Allosteric inhibition enhances the efficacy of ABL kinase inhibitors to target unmutated BCR-ABL and BCR-ABL-T315I
by: Mian Afsar, et al.
Published: (2012-09-01)

Prinsip-prinsip asas QCC /
by: Perbadanan Produktiviti Negara, et al.
Published: (1994)

Konvensyen QCC Kebangsaan 1995 /
by: Konvensyen QCC Kebangsaan (1995 : Johor Bahru), et al.
Published: (1995)

Pterostilbene downregulates BCR/ABL and induces apoptosis of T315I-mutated BCR/ABL-positive leukemic cells
by: Shohei Kawakami, et al.
Published: (2022-01-01)

Droplet Digital PCR for <i>BCR–ABL1</i> Monitoring in Diagnostic Routine: Ready to Start?
by: Maria Teresa Bochicchio, et al.
Published: (2021-10-01)

An In-house Method for Molecular Monitoring of BCR-ABL
by: Hakkı Ogun Sercan, et al.
Published: (2012-12-01)

No Benefit of BCR-ABL1 Screening in Polycythemia
by: STEPHEN E. LANGABEER
Published: (2016-07-01)

The HSP90 inhibitor KW-2478 depletes the malignancy of BCR/ABL and overcomes the imatinib-resistance caused by BCR/ABL amplification
by: Dachuan Zeng, et al.
Published: (2022-05-01)

Peptides spanning the junctional region of both the abl/bcr and the bcr/abl fusion proteins bind common HLA class I molecules.
by: Berke, Z, et al.
Published: (2000)

Combined inhibition of BCR-ABL1 and the proteasome as a potential novel therapeutic approach in BCR-ABL positive acute lymphoblastic leukemia
by: Saskia Maletzke, et al.
Published: (2022-01-01)

Combined inhibition of BCR-ABL1 and the proteasome as a potential novel therapeutic approach in BCR-ABL positive acute lymphoblastic leukemia.
by: Saskia Maletzke, et al.
Published: (2022-01-01)

Effect of Ras Inhibition in Hematopoiesis and BCR/ABL Leukemogenesis
by: Baum Karina J, et al.
Published: (2008-06-01)

BCR/ABL positive thrombocythemia: a diagnostic dilemma
by: Lubna Zafar, et al.
Published: (2017-01-01)

The functional interplay between the t(9;22)-associated fusion proteins BCR/ABL and ABL/BCR in Philadelphia chromosome-positive acute lymphatic leukemia.
by: Anahita Rafiei, et al.
Published: (2015-04-01)

Kumpulan mutu kerja (QCC) : satu bibliografi
by: Institut Teknologi MARA. Perpustakaan (Cawangan Petaling Jaya)
Published: ([199)

A Small Molecule Inhibitor, OGP46, Is Effective against Imatinib-Resistant BCR-ABL Mutations via the BCR-ABL/JAK-STAT Pathway
by: Liuya Wei, et al.
Published: (2020-09-01)

Nickel pyrithione induces apoptosis in chronic myeloid leukemia cells resistant to imatinib via both Bcr/Abl-dependent and Bcr/Abl-independent mechanisms
by: Xiaoying Lan, et al.
Published: (2016-11-01)

A Novel ELISA-Based Peptide Biosensor Assay for Screening ABL1 Activity in vitro: A Challenge for Precision Therapy in BCR-ABL1 and BCR-ABL1 Like Leukemias
by: Oksana Montecchini, et al.
Published: (2021-11-01)

Detection of bcr-abl Fusion Gene Expression in Chronic Myelogenous
by: Perpustakaan UGM, i-lib
Published: (2004)

Bcr-Abl Tyrosine Kinase Inhibitors in the Treatment of Pediatric CML
by: Francesca Carofiglio, et al.
Published: (2020-06-01)

BCR-ABL Independent Mechanisms of Resistance in Chronic Myeloid Leukemia
by: Federica Loscocco, et al.
Published: (2019-09-01)

BCR-ABL promotes PTEN downregulation in chronic myeloid leukemia.
by: Cristina Panuzzo, et al.
Published: (2014-01-01)

Sphingomyelin synthase 1 activity is regulated by the BCR-ABL oncogene[S]
by: Tara Ann Burns, et al.
Published: (2013-03-01)

Transcripto BCR-ABL atípico en un paciente con leucemia mieloide crónica Atypical BCR-ABL transcript in a patient with chronic myeloid leukemia
by: Ana María Amor Vigil, et al.
Published: (2011-09-01)

Detection of p190BCR-ABL AND p210BCR-ABL fusion transcripts in patients with chronic myeloid leukemia (CML) using qualitative RT-PCR
by: Aya Bonilla, Carlos Alberto, et al.
Published: (2014-10-01)

Combination of bortezomib and mitotic inhibitors down-modulate Bcr-Abl and efficiently eliminates tyrosine-kinase inhibitor sensitive and resistant Bcr-Abl-positive leukemic cells.
by: Octavian Bucur, et al.
Published: (2013-01-01)

Successful treatment with ABL tyrosine kinase inhibitor for patients with acute myeloid leukemia with BCR-ABL1
by: Asako Takeuchi, et al.
Published: (2021-01-01)

Major molecular response achievement in CML Patients can be predicted by BCR-ABL1/ABL1 or BCR-ABL1/GUS ratio at an earlier time point of follow-up than currently recommended.
by: Sarah Huet, et al.
Published: (2014-01-01)

A kinase-independent role for CDK8 in BCR-ABL1+ leukemia
by: Ingeborg Menzl, et al.
Published: (2019-10-01)

Oncogenic stress induced by acute hyper-activation of Bcr-Abl leads to cell death upon induction of excessive aerobic glycolysis.
by: Michael A Dengler, et al.
Published: (2011-01-01)

Consensus on BCR-ABL1 reporting in chronic myeloid leukaemia in the UK
by: Cross, N, et al.
Published: (2018)